We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
Compumedics (ASX:CMP) has seen record sales orders and continued momentum across its core and emergi...
Read ArticleFor veteran brain and health diagnostic outfit Compumedics (ASX:CMP), it’s time to deploy what found...
Read ArticleCompumedics (ASX:CPM), a world leader in sleep and neuro diagnostics, is growing as a company, which...
Read ArticleWhile sector conditions are improving, investors still can pick up marked-down, revenue-generating...
Read ArticleThe S&P ASX 200 Health Care index fell 13.21% in August as a tough reporting season weighed on...
Read ArticleCompumedics shares surge up to 13% after FDA approval of its Somfit D device Don’t miss out on an o...
Read ArticleCompumedics secures two lucrative sales for its Somfit sleep device with combined revenues approach...
Read ArticleThe S&P ASX 200 Health Care index rose 9.05% in July with rotation into the sector gaining mome...
Read ArticleA trade deal between the EU and US has staved off the worst tariff fears Telecoms led gains alongsi...
Read ArticleCompumedics signs two lucrative four-year distribution deals in Asia strengthening footprint in reg...
Read ArticleCompumedics (ASX: CMP) has marked a strategic turning point in its development after posting record...
Read ArticleASX walks tightrope to slide just 9.7 points All Ords gold sub-index climbs 1.87pc Iron ore prices...
Read ArticleCompumedics achieves record revenue of $51 million and sales orders of $63.4 million in FY25 Compan...
Read ArticleImugene reports two more ‘complete responders’ in its cell therapy trial Clever Culture Systems sha...
Read ArticleMorning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the...
Read ArticleThe ASX 200 Health Care Index fell 1.05% in June and remains the worst performing sector YTD down 6...
Read ArticleChina Brain Project rolls out neuro-AI push Compumedics dual-helmet MEG lights up Tianjin labs ASX...
Read ArticleTwo equity research firms endorse Compumedics and see upside to share price Recent FDA clearance fo...
Read ArticleVital Signs is a podcast series focused on investing, hosted by Senior Health and Biotech journalist...
Read ArticleThe S&P/ASX 200 Health Care Index rose 1.59% in May but remains worst performing sector YTD dow...
Read ArticleCompumedics wins new Somfit sale worth about $1 million to one of the world’s leading pharmaceutica...
Read ArticleHighlights: ASX 200 opens lower, ending a recent winning streak amid softer commodity sentimen...
Read ArticleCompumedics’ MEG unit can scan adult and kid’s heads at the same time – a technically tricky task M...
Read ArticleCompumedics Neuroscan Orion LifeSpan magnetoencephalography system records brain activity in childr...
Read ArticleASX medtechs are taking brain diagnostics beyond the hospital or clinical settings to the front lin...
Read ArticleThe S&P/ASX 200 Health Care Index rose 2.16% in April with the S&P/ASX 200 rallying 3.6% Mo...
Read ArticleSandoz backs Avecho in $3m CBD sleep capsule play Neurotech also eyes sleep as secondary endpoint i...
Read ArticleCompumedics founder David Burton says brain imaging can rival the magnetic resonance imaging (MRI)...
Read ArticleDonald Trump exempts “pharmaceuticals” from his tariff blitz ASX device makers mull their US manufa...
Read ArticleIn the arvo session, the ASX held on to early gains… by a thread Nervy investor/trader eyes now awa...
Read ArticleCompumedics receives new order for Neuroscan Orion LifeSpan MEG system in China The order will brin...
Read ArticleASX up as it notches one of best weeks of the year Woolies, Coles win big, miners hit hard on Trump...
Read ArticleBrain research technologies specialist Compumedics (ASX: CMP) has reached $20 million in sales for i...
Read ArticleTBI awareness month highlights need for better care ASX companies roll out devices to tackle TBI he...
Read ArticleNanosonics shares pop 13% after getting the FDA’s nod for its next-gen sterilising device Imricor...
Read ArticleCompumedics receives US FDA clearance for its Falcon home sleep testing solution Falcon to comple...
Read ArticleThe S&P/ASX 200 Health Care Index fell 7.66% in February with the S&P/ASX 200 down 3.79% Mo...
Read ArticleStockhead’s Road to 2025 video series highlights companies’ key 2024 achievements and the routes the...
Read ArticleMelbourne-based medical device company Compumedics (ASX: CMP) has chalked up record orders totalling...
Read ArticleThe S&P/ASX 200 Health Care Index fell 1.85% in December but rose 7.51% overall in 2024 Mesobl...
Read ArticleFrom artificial intelligence (A.I) to zygotes, the biotech sector this year delivered the A to Z of...
Read ArticleThe S&P/ASX 200 Health Care Index rose 2.89% in November as momentum returned to the sector Hea...
Read ArticleToothy white smiles as SDI reports strong initial sales of its company-making Stela fillings Triva...
Read ArticleASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results...
Read ArticleHealthcare stocks are doing relatively well globally in 2024 The sector could see more recovery as...
Read ArticleClinuvel chairman tells restless investors the company is on track despite share price weakness Op...
Read ArticleWall Street had mixed results; but focus turns to tonight’s US jobs report Nvidia and Tesla saw gai...
Read ArticleASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing;...
Read ArticleSleep is essential for wellbeing but often overlooked in healthy habits Compumedics designs and man...
Read ArticleS&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expec...
Read ArticleThe EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-l...
Read ArticleASX 200 punches it, record highs back in view 11 of 11 sectors higher, like a well-oiled machine...
Read ArticleThe ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biot...
Read ArticleThe ASX took a slow dive to a 50-point slump before a weak post-lunch rally Big gains for some big...
Read ArticleAussie shares rally Rate sensitive stocks gain, led by Tech FTL soars on Newfoundland deal Aussi...
Read ArticleS&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biot...
Read ArticleResearch shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase th...
Read ArticleEcho IQ is awaiting FDA approval for its AI-powered EchoSolv platform EchoSolv utilises machine lea...
Read ArticleASX Health sector was in correction territory in April Why is the health sector different from othe...
Read ArticleThere’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to c...
Read ArticleViking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on p...
Read ArticleMomentum investing has been shown to be a successful strategy over the long term. The strategy essen...
Read ArticleA momentum trader will essentially be “buying high, but hoping to sell even higher” – which is the c...
Read ArticleThe S&P ASX 200 rose 1.19% in January to finish at a record high Energy was the winner with a 5...
Read ArticleThe ASX benchmark has closed slightly lower on Friday Losses across the Energy Sector weighed Smal...
Read ArticleXi and Biden set to agree on restricting fentanyl Fentanyl is a synthetic opioid responsible for t...
Read ArticleThe ASX has ended Wednesday jumping almost 100 points. Huge effort, everyone Energy Sector misses o...
Read ArticleNews relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD f...
Read ArticleL’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supr...
Read ArticleBenchmark slides throughout the day after a shocker on Wall Street last night. Utilities did best b...
Read ArticleThe ASX 200 benchmark falls 0.6% as we brace for news from The Fed Sector losses led by Resources,...
Read ArticleThe FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergenc...
Read ArticleEarnings reports dominated headlines in August Despite solid results from ASX healthcare giants, th...
Read ArticleAustralian biotech has attracted US investments in the last five years Among ASX stocks to get fund...
Read ArticleBiotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two g...
Read ArticleThe end of pandemic and higher rates have subdued biotech market But there are signs now the sector...
Read ArticleBrisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “gam...
Read ArticleSmall cap health stocks are not known to pay dividends But there’s a handful of such stocks on the...
Read ArticleBiotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We...
Read ArticlePfizer said its diabetes drug works as well as Ozempic for weight loss What are the side effects of...
Read ArticleThe Federal Budget delivers billions of dollars funding into healthcare and aged care Mental health...
Read ArticleArtificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discove...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleThe FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have g...
Read ArticleJapanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based devic...
Read ArticleASX 200 down 0.41% on lower than normal volume Small cap index falls 1.17% and 7 out 11 sectors f...
Read ArticleASX health stocks have been out of favour this year with rotation away from growth to value sector...
Read ArticleWe take a look at how the 15 biotech IPOs that listed in 2021 are faring now Only two IPO stocks fr...
Read ArticleUS FDA approves the first clinical trial using naturally derived psychedelic drugs It could open po...
Read ArticleUS inflation is at the highest level in 41 years Wall Street was down, but didn’t react strongly to...
Read ArticleThe ASX 200 ends ever so slightly up, XEC finds 0.4% Gains in consumer discretionary, tech offset b...
Read ArticleA recent research reveals which biotech segments VCs are ploughing billions of dollars into We list...
Read ArticleBoth ASX Small Cap and benchmark index are down about 0.5% A bleak forecast from Covid-stricken Chi...
Read ArticleAussie small cap index falls flat, day two The ASX200 up 0.65% Conico is 50% higher Rising gold...
Read ArticleAussie small cap index falls 1.4% The ASX200 down 1.65% Thursday is Arafura Day! Down less than...
Read ArticleThe Healthcare sector has been struggling as the pandemic wanes But most money managers are still b...
Read ArticleThe healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak mark...
Read ArticleBiotech sector has had a tough time recently But there are signs of things improving this year A lo...
Read ArticleTelehealth was already a growing space even before the pandemic, but COVID had launched it into the...
Read ArticleThe ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial t...
Read ArticleThe share price in software company Data#3 Limited (ASX:DTL) has risen around ~12% in morning trade...
Read ArticleThe ASX edged higher in a fairly directionless session in Thursday trade, after US markets comfortab...
Read ArticleImmuron nabs $6.2m clinical research deal for US Military strength Travelan dose ECS Botanics repor...
Read ArticleCompumedics has begun the new calendar year with strong sales growth up 33% from the same period las...
Read ArticleUS markets were more buoyant overnight, after Federal Reserve Chairman Jerome Powell provided some e...
Read ArticleIt was a lacklustre session for local stocks in Tuesday trade, as the ASX 200 limped into the close...
Read ArticleLocal stocks made a cautious start to the week, following a fairly volatile trading period last week...
Read ArticleAt the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, be...
Read ArticleIt’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 los...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 los...
Read ArticleAlthough earnings results were the main theme in August, there were also some notable healthcare bre...
Read ArticleThe company continues to actively pursue step-out commercial growth opportunities for the MEG and So...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 7...
Read ArticleThe ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 7...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has ret...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks f...
Read ArticleSummary Logistic problems have impacted the revenue pipeline of the company. Compumedics contin...
Read ArticleLast week in our discussion with Bourse Communication founder and Managing Director Rod North, we ex...
Read ArticleIn just two years, skin regenerator Avita Medical (ASX:AVH) has shot up from 6c to 40c and was grant...
Read ArticleThe Compumedics Limited (ASX: CMP) share price will be one to watch this morning following the rele...
Read ArticleAt time of writing, the share price of Compumedics Ltd [ASX:CMP] is up a significant 25.47% on impor...
Read ArticleAnother ASX small cap has won the blessing of the Food and Drug Administration (FDA) for its product...
Read ArticleCompumedics (ASX: CMP) has collared US Food and Drug Administration approval for its neuroimaging te...
Read ArticleThe Compumedics Limited (ASX: CMP) share price has started the week with a bang. In morning trade t...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleAsia is rising as a healthcare spender, matching incomes and the long-feared elderly population boom...
Read ArticleIn afternoon trade the S&P/ASX 200 index is on course to start the week on a disappointing note...
Read ArticleNo one likes to hear of a revenue downgrade and shareholders of sleep and brain disorder medical dev...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleThe Compumedics Limited (ASX: CMP) share price is crashing lower on Monday. At the time of writing...
Read ArticleIn 2019 the culmination of decades worth of work turned several biotechs and life sciences companies...
Read Article
Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
